[Drugs in medical practice. Prescription and control].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced; D004071:Digitalis Glycosides / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D011307:Drug Prescriptions / Q000592:standards*; D004335:Drug and Narcotic Control / Q000379:methods*; D006029:Glycosuria / Q000175:diagnosis; D006801:Humans; D011619:Psychotropic Drugs / Q000009:adverse effects; D011674:Pulse; D012110:Reserpine / Q000009:adverse effects; D014665:Vasodilator Agents / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000970:Antineoplastic Agents; D004071:Digitalis Glycosides; D004232:Diuretics; D011619:Psychotropic Drugs; D014665:Vasodilator Agents; D012110:Reserpine
Arzneimittel in der Praxis. Verordnung und Kontrolle.